Baycol Injuries Class Action Lawsuit
Result: Confidential settlements
Year: 2006
In re Baycol Products Litigation
Baycol was one of a group of drugs called statins, intended to reduce cholesterol. In August 2001, Bayer A.G. and Bayer Corporation, the manufacturers of Baycol, withdrew the drug from the worldwide market based upon reports that Baycol was associated with serious side effects and linked to the deaths of over 100 patients worldwide.
In the federal multi-district litigation, Lieff Cabraser served as a member of the Plaintiffs’ Steering Committee (PSC) and the Executive Committee of the PSC. In addition, Lieff Cabraser represented approximately 200 Baycol patients who suffered injuries or family members of patients who died allegedly as a result of ingesting Baycol. In these cases, our clients reached confidential favorable settlements with Bayer.
Civil Litigation News
San Francisco Schools Receive Financial Boost From Settlement With JUUL
As reported by the S.F. Chronicle, the San Francisco Unified School District has been awarded a substantial $24.65
Final Approval Granted to Historic $235M Settlement with Altria in National JUUL Youth E-Cigarette Predatory Advertising, Addiction and Injury Litigation
On March 14, 2024, U.S. District Judge William Orrick of the Northern District of California issued an order granting final approval to a comprehensive
New York Times Spotlights Lieff Cabraser’s Recent Win on Behalf of Hawaiian Kona Coffee Farmers
The New York Times has published an exemplary piece highlighting Lieff Cabraser’s leadership in securing a pivotal victory for Kona coffee farmers
